Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

PROFENAL

SUPROFEN

Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PROFENAL is listed in Drugs@FDA under application 019387 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SUPROFEN Form and strength SOLUTION/DROPS;OPHTHALMIC - 1% Sponsor ALCON Submission history Latest submission status date: 2000-02-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROFENAL is listed in Drugs@FDA under application 019387 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SUPROFEN Form and strength SOLUTION/DROPS;OPHTHALMIC - 1% Sponsor ALCON Submission history Latest submission status date: 2000-02-18 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.